Unknown

Dataset Information

Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea.


ABSTRACT: Although well established for the treatment of certain hematologic malignancies, maintenance therapy has only recently become a treatment paradigm for advanced non-small-cell lung cancer. Maintenance therapy, which is designed to prolong a clinically favorable state after completion of a predefined number of induction chemotherapy cycles, has two principal paradigms. Continuation maintenance therapy entails the ongoing administration of a component of the initial chemotherapy regimen, generally the nonplatinum cytotoxic drug or a molecular targeted agent. With switch maintenance (also known as sequential therapy), a new and potentially non-cross-resistant agent is introduced immediately on completion of first-line chemotherapy. Potential rationales for maintenance therapy include increased

SUBMITTER: Gerber DE 

PROVIDER: S-EPMC3589699 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature